GIM
LH icon

Glenmede Investment Management’s Labcorp LH Stock Holding History

Glenmede Investment Management’s Portfolio LH Stock Details LH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		$77.7M Sell
270,547
-4,365
-2% -$1.17M 0.37% 59
2025
Q2 		$72.2M Buy
+274,912
New +$66.9M 0.37% 61

Other funds holding LH

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $59.7B AUM 29.08% 1-Year Est. Return
Select Equity Group
Select Equity Group New York $19.5B AUM 17.33% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Diamond Hill Capital Management
Diamond Hill Capital Management Columbus, Ohio $16B AUM 4.15% 1-Year Est. Return

Glenmede Investment Management's LH Position: Q3 2025 in Review

Glenmede Investment Management reduced its Labcorp (LH) stake by 1.6% in Q3 2025, selling an estimated $1.17M and leaving 270,547 shares worth $77.7M. The position accounts for 0.37% of the portfolio, ranked #59.

Glenmede Investment Management first reported a position in LH in Q2 2025 and has held it in 2 quarters since. 1,008 funds tracked by Wall St. Rank hold LH as of Q3 2025.

  • Glenmede Investment Management held 270,547 shares of Labcorp worth $77.7M as of Q3 2025.
  • Glenmede Investment Management sold 4,365 Labcorp shares in Q3 2025, an estimated $1.17M.
  • Labcorp made up 0.37% of Glenmede Investment Management's portfolio in Q3 2025, its #59 holding.
  • Glenmede Investment Management first reported a position in Labcorp in Q2 2025 and has held it in 2 quarters since.
  • 1,008 funds tracked by Wall St. Rank held Labcorp as of Q3 2025.

Based on Glenmede Investment Management's 13F filing for Q3 2025, filed 13 Nov 2025.